Osteoarthritis of the Shoulder
1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
MedpaceFX006
StrykerAequalis Pyrocarbon Humeral Head
Zimmer BiometBiomet Comprehensive Shoulder System
BioventusSUPARTZ®
Clinical Trials (4)
Total enrollment: 555 patients across 4 trials
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis
Start: Nov 2019Est. completion: Jun 202019 patients
Phase 2Terminated
Pyrocarbon Clinical Follow-up Study
Start: Oct 2021Est. completion: Dec 202776 patients
N/AActive Not Recruiting
Database Retrieval for the Comprehensive Shoulder
Start: Feb 2011Est. completion: Dec 2026160 patients
N/AActive Not Recruiting
SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder
Start: May 2007Est. completion: Oct 2009300 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.